Puma Biotechnology (PBYI) Tax Provisions (2020 - 2026)
Puma Biotechnology (PBYI) reported Tax Provisions of $326000.0 for Q1 2026, up 11.26% on a YoY basis from $293000.0 in Q1 2025, and down 23.11% quarter-over-quarter from $424000.0 in Q4 2025.
Puma Biotechnology (PBYI) Tax Provisions (2020 - 2026) Analysis & Trends
Puma Biotechnology has reported Tax Provisions for 7 years, with the latest figure at $326000.0 in Q1 2026.
- For the quarter ending Q1 2026, Tax Provisions rose 11.26% year-over-year to $326000.0; the trailing twelve-month figure through Mar 2026 stood at $1.5 million (up 83.52% YoY), and the FY2025 full-year result was $1.4 million, up 97.51% from the prior year.
- Tax Provisions for Q1 2026 stood at $326000.0, down from $424000.0 in the prior quarter.
- The five-year high for Tax Provisions was $536000.0 in Q4 2023, with the low at -$167000.0 in Q4 2024.
- Historically, Tax Provisions has averaged $230588.2 across 5 years, with a median of $220000.0 in 2024.
- Annual changes were most pronounced in 2024 — Tax Provisions slumped 131.16% — and 2025, when it surged 353.89%.
- Puma Biotechnology's Tax Provisions stood at $202000.0 in 2022, then soared by 165.35% to $536000.0 in 2023, then sank by 131.16% to -$167000.0 in 2024, then soared by 353.89% to $424000.0 in 2025, then fell by 23.11% to $326000.0 in 2026.
- The last three Tax Provisions figures came in at $326000.0 (Q1 2026), $424000.0 (Q4 2025), and $399000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -11.20 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 216,000.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -859,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 221.50 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Puma Biotechnology | 384.39 Mn | 282.84 Mn | 34.39 Mn | 326,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 326,000.00 |
| Dec 31, 2025 | 424,000.00 |
| Sep 30, 2025 | 399,000.00 |
| Jun 30, 2025 | 310,000.00 |
| Mar 31, 2025 | 293,000.00 |
| Dec 31, 2024 | -167,000.00 |
| Sep 30, 2024 | 291,000.00 |
| Jun 30, 2024 | 378,000.00 |
| Mar 31, 2024 | 220,000.00 |
| Dec 31, 2023 | 536,000.00 |
| Sep 30, 2023 | 213,000.00 |
| Jun 30, 2023 | 187,000.00 |
| Mar 31, 2023 | 147,000.00 |
| Dec 31, 2022 | 202,000.00 |
| Sep 30, 2022 | 67,000.00 |
| Jun 30, 2022 | 57,000.00 |
| Mar 31, 2022 | 37,000.00 |
| Dec 31, 2021 | 212,000.00 |
| Sep 30, 2021 | 37,000.00 |
| Jun 30, 2021 | 38,000.00 |